BioLargo, Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 6/16/2017
Contact Info
  • 14921 Chestnut St
  • Westminster, CA 92683

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0000880242
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2800 - Chemicals & Allied Products
Incorporated In: DE, USA
Year of Inc. 1987
Employees 19 a/o Jun 15, 2017
Company Officers/Contacts
Dennis Calvert President, CEO, IR
Charles Dargan II CFO
Joseph Provenzano Secretary
Kenneth Code CSO
AJ Sexton V Director, Bus. Dev.
John Browning General Counsel
Company Directors
Dennis Calvert
Gary Cox
Kent C. Roberts II
Dennis Marshall
Joseph Provenzano
Kent Roberts
John S. Runyan
Company Notes
  • Formerly=NuWay Medical, Inc. until 3-07
  • Formerly=NuWay Energy, Inc. until 11-02
  • Formerly=Latin American Casinos, Inc. until 8-01
  • Formerly=Repossession Auction, Inc. to 6-94
Service Providers
Accounting/Auditing Firm
Haskell & White LLP
300 Spectrum Drive
Suite 300
Irvine, CA, 92618
United States

Legal Counsel
Not Available
Investor Relations Firm
UPTICK Newswire
10000 N 31st Ave
Suite C-105
Phoenix, AZ, 85051
United States

BLGO Security Details
Share Structure
Market Value1 $51,298,546 a/o Sep 18, 2017
Authorized Shares 200,000,000 a/o May 19, 2017
Outstanding Shares 100,585,385 a/o Aug 11, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 65,557,822 a/o May 19, 2017
Par Value 0.00067
Shareholders of Record 653 a/o May 19, 2017
Short Selling Data
Short Interest 3,951 (-64.72%)
Aug 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security